BioWorld

Aug. 21, 2003

View Archived Issues

GTx Financing Pulls Down $20M To Advance Men's Health Drugs

Read More

MultiCell Pushes Liver Proteins With $18M XenoTech Contract

Read More

Neurochem Files For U.S. IPO As Well As Follow-On In Canada

Read More

Other News To Note

Read More

Rinat Secures $40M In Series B Round To Advance Neuro Drugs

Rinat Neuroscience Corp. returned to the private financing well and brought in $40 million through a Series B round that will fund drug development for the next several years. (BioWorld Today) Read More

Nucleonics Licenses RNAi Rights From Wyeth For 5 Percent Stake

Read More